Answer
St John's wort is contraindicated during Imbruvica (ibrutinib) treatment because CYP3A4 induction can decrease ibrutinib plasma concentrations and reduce efficacy.
Sources for this answer
- IMBRUVICA 140 mg film-coated tablets (Great Britain)Janssen-Cilag Ltd (a Johnson & Johnson Company) · emc · SmPC §4.5 Interaction with other medicinal products · Version 25Document updated
Sources checked